RBF Capital’s XBiotech XBIT Stock Holding History

RBF Capital’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$466K	Hold	198,501	–	–	0.02%	375
2025 Q4	$474K	Sell	198,501 -1,499	-0.7%	-$3.69K	0.02%	408
2025 Q3	$532K	Hold	200,000	–	–	0.02%	400
2025 Q2	$594K	Buy	+200,000	New	+$581K	0.03%	397
2022 Q4	–	Sell	-23,172	Closed	-$84K	–	590
2022 Q3	$84K	Buy	+23,172	New	+$109K	0.01%	502

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RBF Capital's XBIT Position: Q1 2026 in Review

RBF Capital held its XBiotech (XBIT) position steady in Q1 2026 at 198,501 shares worth $466K. The position accounts for 0.02% of the portfolio, ranked #375.

RBF Capital first reported a position in XBIT in Q3 2022 and has held it in 5 quarters since. The position peaked at $594K in Q2 2025. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

RBF Capital held 198,501 shares of XBiotech worth $466K as of Q1 2026.
RBF Capital left its XBiotech share count unchanged in Q1 2026.
XBiotech made up 0.02% of RBF Capital's portfolio in Q1 2026, its #375 holding.
RBF Capital first reported a position in XBiotech in Q3 2022 and has held it in 5 quarters since.
RBF Capital's XBiotech position peaked at $594K in Q2 2025.
37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on RBF Capital's 13F filing for Q1 2026, filed 15 May 2026.